HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION (EIN 411855605) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

LISA SALBERG

Phone

9739837429

Tax Period

2023-01-01 to 2023-12-31

HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION, founded in 1996, is a community nonprofit in the Diseases & Disorders sector that reported $1.3M in total revenue in fiscal year 2023. Revenue grew 20% year-over-year, indicating healthy expansion. The organization ran a surplus of $246K, a strong 19% operating margin.

Mission

TO PROVIDE SUPPORT, ADVOCACY AND EDUCATION TO PATIENTS, FAMILIES, THE MEDICAL COMMUNITY AND THE PUBLIC ABOUT HYPERTROPHIC CARDIOMYOPATHY, WHILE SUPPORTING RESEARCH AND FOSTERING THE DEVELOPMENT OF TREATMENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $979,965

Program Service Revenue $247,716

Investment Income $10,816

Other Revenue $87,765

TOTAL REVENUE $1,326,262

Expense Breakdown

Grants Paid $0

Salaries & Benefits $605,349

Fundraising Expenses $58,068

Program Expenses $717,022

Other Expenses $475,127

TOTAL EXPENSES $1,080,476

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,326,262	$1,106,885	+0.2%
Expenses	$1,080,476	$796,317	+0.4%
Net Income	$245,786	$310,568	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$105,000

Total Directors

$105,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LISA SALBERG	CEO/VICE CHAIR	40.00	Officer Director	$98,908	$6,092	$105,000
GORDON FOX PHD	CHAIR	10.00	Officer Director	$0	$0	$0
ADAM SALBERG	SECRETARY	1.00	Officer Director	$0	$0	$0
ROB LORFINK	TREASURER	1.00	Officer Director	$0	$0	$0
AMIT KALIA PHD	DIRECTOR	2.00	Director	$0	$0	$0
ROSEMARY CONLON	DIRECTOR	1.00	Director	$0	$0	$0
BILLUR DOWSE	DIRECTOR	10.00	Director	$0	$0	$0
MARTIN MARON MD	DIRECTOR	2.00	Director	$0	$0	$0
MIKE LYNCH MD	DIRECTOR	1.00	Director	$0	$0	$0
KEVIN O'CONNOR MD	DIRECTOR	1.00	Director	$0	$0	$0
ISAAC RODRIGUEZ-CHAVEZ PHD MHS MS	DIRECTOR	1.00	Director	$0	$0	$0
BILL ROSSI	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD MELIA PHD EMERITUS	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,326,262	$1,080,476	$1,398,852	$245,786
2022	$1,106,885	$796,317	$1,085,584	$310,568
2021	$804,960	$531,813	$577,031	$273,147
2020	$390,972	$374,280	$313,163	$16,692
2019	$320,578	$191,775	$296,471	$128,803
2018	$355,678	$192,098	$167,668	$163,580

HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION